{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T10:19:22Z","timestamp":1788430762888,"version":"build-2803163510"},"reference-count":58,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trop. Med. Infect. Dis.","TropicalMed"],"abstract":"<jats:p>West Nile virus (WNV) is an expanding mosquito-borne orthoflavivirus and an important cause of arboviral neuroinvasive disease. Whether HIV infection modifies WNV susceptibility, severity, or diagnostic performance remains uncertain. This narrative review was supported by structured PubMed\/MEDLINE and Scopus searches updated to 22 August 2026 and a supplementary targeted citation search, identifying 23 peer-reviewed reports providing direct clinical or seroepidemiological evidence on WNV in people with HIV (PWH). The evidence remains heterogeneous, but recent data clarify several conclusions. A Northern Italian sero-repository study of 2843 PWH found neutralization-confirmed WNV antibodies in 3.0%, with no neuroinvasive disease and no association with HIV-related immunological variables. Comparative US cohorts likewise do not demonstrate that HIV status alone confers a uniform excess risk of WNV neuroinvasive disease. Conversely, individual reports of advanced HIV disease describe severe neuroinvasive presentations with delayed or absent WNV-specific antibody responses and molecular confirmation. HIV status alone should therefore not be considered a uniform WNV risk marker; the individual immune phenotype may be more clinically informative. In PWH with profound immunosuppression, negative early serology should not prematurely exclude WNV, and molecular testing should be considered when clinical suspicion remains high. Prevention, seasonal vigilance, and prospective HIV-specific studies remain priorities.<\/jats:p>","DOI":"10.3390\/tropicalmed11090250","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T09:20:43Z","timestamp":1788427243000},"page":"250","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["West Nile Virus in People with HIV: Immune Vulnerability, Neuroinvasive Disease, and Diagnostic Challenges"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3949-4293","authenticated-orcid":false,"given":"Paolo","family":"Fusco","sequence":"first","affiliation":[{"name":"Infectious and Tropical Diseases Unit, \u201cRenato Dulbecco\u201d Teaching Hospital of Catanzaro, Viale Europa, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9687-4841","authenticated-orcid":false,"given":"Francesco","family":"De Maria","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, \u201cMagna Graecia\u201d University of Catanzaro, Campus Universitario \u201cSalvatore Venuta\u201d, Viale Europa, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3846-4620","authenticated-orcid":false,"given":"Alessandro","family":"Russo","sequence":"additional","affiliation":[{"name":"Infectious and Tropical Diseases Unit, \u201cRenato Dulbecco\u201d Teaching Hospital of Catanzaro, Viale Europa, 88100 Catanzaro, Italy"},{"name":"Department of Medical and Surgical Sciences, \u201cMagna Graecia\u201d University of Catanzaro, Campus Universitario \u201cSalvatore Venuta\u201d, Viale Europa, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s00705-023-05835-1","article-title":"Renaming of the genus Flavivirus to Orthoflavivirus and extension of binomial species names within the family Flaviviridae","volume":"168","author":"Postler","year":"2023","journal-title":"Arch. Virol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1128\/CMR.00045-12","article-title":"West Nile virus: Biology, transmission, and human infection","volume":"25","author":"Colpitts","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.3201\/eid1108.050289b","article-title":"Virology, pathology, and clinical manifestations of West Nile virus disease","volume":"11","author":"Hayes","year":"2005","journal-title":"Emerg. Infect. Dis."},{"key":"ref_4","unstructured":"European Centre for Disease Prevention and Control (2026, August 22). Factsheet About West Nile Virus Infection. Available online: https:\/\/www.ecdc.europa.eu\/en\/west-nile-fever\/facts."},{"key":"ref_5","unstructured":"World Health Organization Regional Office for Europe (2026, August 22). West Nile Virus: As Cases Rise Across Parts of Europe, Here Is What You Need to Know. Available online: https:\/\/www.who.int\/europe\/news\/item\/24-07-2026-west-nile-virus--as-cases-rise-across-parts-of-europe--here-is-what-you-need-to-know."},{"key":"ref_6","unstructured":"European Centre for Disease Prevention and Control (2026, August 22). Surveillance of West Nile Virus Infections in Humans in Europe, Weekly Report\u2014Week 33, 2026. Produced 14 August 2026; Data Submitted Up to 13 August 2026. Available online: https:\/\/wnv-weekly.ecdc.europa.eu\/."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1001\/jama.2025.8737","article-title":"West Nile virus: A review","volume":"334","author":"Gould","year":"2025","journal-title":"JAMA"},{"key":"ref_8","unstructured":"Centers for Disease Control and Prevention (2026, August 22). Signs and Symptoms of West Nile Virus, Available online: https:\/\/www.cdc.gov\/west-nile-virus\/signs-symptoms\/index.html."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4269\/ajtmh.2012.12-0113","article-title":"Medical risk factors for severe West Nile virus disease, United States, 2008\u20132010","volume":"87","author":"Lindsey","year":"2012","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e244294","DOI":"10.1001\/jamanetworkopen.2024.4294","article-title":"Neuroinvasive West Nile virus infection in immunosuppressed and immunocompetent adults","volume":"7","author":"Mbonde","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-med-042909-093756","article-title":"HIV infection, inflammation, immunosenescence, and aging","volume":"62","author":"Deeks","year":"2011","journal-title":"Annu. Rev. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"6825493","DOI":"10.1155\/2017\/6825493","article-title":"HIV as a cause of immune activation and immunosenescence","volume":"2017","author":"Sokoya","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S1473-3099(10)70117-1","article-title":"Dysfunctional B-cell responses during HIV-1 infection: Implication for influenza vaccination and highly active antiretroviral therapy","volume":"10","author":"Cagigi","year":"2010","journal-title":"Lancet Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1468-1293.2010.00857.x","article-title":"Late presentation of HIV infection: A consensus definition","volume":"12","author":"Antinori","year":"2011","journal-title":"HIV Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1111\/hiv.13425","article-title":"Late diagnosis of HIV: An updated consensus definition","volume":"23","author":"Croxford","year":"2022","journal-title":"HIV Med."},{"key":"ref_16","unstructured":"World Health Organization (2026, July 08). Advanced HIV Disease. Available online: https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/hiv\/treatment\/advanced-hiv-disease."},{"key":"ref_17","unstructured":"European Centre for Disease Prevention and Control\/WHO Regional Office for Europe (2025). HIV\/AIDS Surveillance in Europe 2025\u20142024 Data, ECDC. Available online: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/hivaids-surveillance-europe-2025-2024-data."},{"key":"ref_18","unstructured":"European Centre for Disease Prevention and Control (2026, July 08). Europe\u2019s Hidden HIV Crisis: Half of All People Living with HIV in Europe Are Diagnosed Late. Available online: https:\/\/www.ecdc.europa.eu\/en\/news-events\/europes-hidden-hiv-crisis-half-all-people-living-hiv-europe-are-diagnosed-late."},{"key":"ref_19","first-page":"9488051","article-title":"HIV Late Presenters in Asia: Management and Public Health Challenges","volume":"2023","author":"Wong","year":"2023","journal-title":"AIDS Res. Treat."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrmicro2950","article-title":"West Nile virus infection and immunity","volume":"11","author":"Suthar","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3390\/v3060811","article-title":"West Nile virus: Immunity and pathogenesis","volume":"3","author":"Lim","year":"2011","journal-title":"Viruses"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1128\/JVI.77.4.2578-2586.2003","article-title":"B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus","volume":"77","author":"Diamond","year":"2003","journal-title":"J. Virol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1084\/jem.20031223","article-title":"A critical role for induced IgM in the protection against West Nile virus infection","volume":"198","author":"Diamond","year":"2003","journal-title":"J. Exp. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"12060","DOI":"10.1128\/JVI.01650-06","article-title":"CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system","volume":"80","author":"Sitati","year":"2006","journal-title":"J. Virol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"8312","DOI":"10.1128\/JVI.78.15.8312-8321.2004","article-title":"Role of CD8+ T cells in control of West Nile virus infection","volume":"78","author":"Shrestha","year":"2004","journal-title":"J. Virol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1084\/jem.20051970","article-title":"CCR5 deficiency increases risk of symptomatic West Nile virus infection","volume":"203","author":"Glass","year":"2006","journal-title":"J. Exp. Med."},{"key":"ref_28","unstructured":"Centers for Disease Control and Prevention (2026, August 22). Clinical Testing and Diagnosis for West Nile Virus Disease, Available online: https:\/\/www.cdc.gov\/west-nile-virus\/hcp\/diagnosis-testing\/index.html."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1056\/NEJM200001063420113","article-title":"West Nile viral encephalitis in an HIV-positive woman in New York","volume":"342","author":"Szilak","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.humpath.2004.04.008","article-title":"Clinicopathologic study and laboratory diagnosis of 23 cases with West Nile virus encephalomyelitis","volume":"35","author":"Guarner","year":"2004","journal-title":"Hum. Pathol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/01.idc.0000214369.54423.f9","article-title":"West Nile virus infection causing hypoglycorrhachia in an HIV-infected man: A case report","volume":"14","author":"Unzek","year":"2006","journal-title":"Infect. Dis. Clin. Pract."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1017\/S0950268806006339","article-title":"Risk factors for encephalitis and death from West Nile virus infection","volume":"134","author":"Murray","year":"2006","journal-title":"Epidemiol. Infect."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.1212\/01.wnl.0000253223.07720.bb","article-title":"West Nile virus infection presenting as acute flaccid paralysis in an HIV-infected patient: A case report and review of the literature","volume":"68","author":"Torno","year":"2007","journal-title":"Neurology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/SMJ.0b013e318153f076","article-title":"A 41-year-old HIV-positive man with acute onset of quadriplegia after West Nile virus infection","volume":"100","author":"Jamison","year":"2007","journal-title":"South. Med. J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1089\/vim.2008.0066","article-title":"Seroprevalence of West Nile virus in Ghana","volume":"22","author":"Wang","year":"2009","journal-title":"Viral Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1128\/JCM.02842-12","article-title":"Atypical presentation of West Nile virus in a newly diagnosed human immunodeficiency virus patient in New York City","volume":"51","author":"Josekutty","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijid.2014.10.010","article-title":"West Nile virus seroprevalence and behavioral risks in HIV-1 infected individuals, Northern Greece, 2011","volume":"30","author":"Pilalas","year":"2015","journal-title":"Int. J. Infect. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4269\/ajtmh.14-0452","article-title":"Epidemiology of meningitis in an HIV-infected Ugandan cohort","volume":"92","author":"Rajasingham","year":"2015","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.nmni.2017.05.018","article-title":"West Nile virus meningitis in a patient with human immunodeficiency virus type 1 infection","volume":"19","author":"Pilalas","year":"2017","journal-title":"New Microbes New Infect."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1177\/1941874418754966","article-title":"Clinical problem-solving: Fever and rapidly progressive weakness in an immunocompromised patient","volume":"8","author":"Albertson","year":"2018","journal-title":"Neurohospitalist"},{"key":"ref_41","first-page":"341","article-title":"Emergence and associated risk factors of vector borne West Nile virus infection in Ilorin, Nigeria","volume":"12","author":"Kolawole","year":"2018","journal-title":"J. Arthropod Borne Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1089\/apc.2017.0286","article-title":"Community-acquired meningitis in HIV-infected patients in the United States","volume":"32","author":"Vigil","year":"2018","journal-title":"AIDS Patient Care STDS"},{"key":"ref_43","first-page":"266","article-title":"Un cas d\u2019enc\u00e9phalite li\u00e9e au virus West Nile import\u00e9 d\u2019Alg\u00e9rie [A case of encephalitis linked to West Nile virus imported from Algeria]","volume":"11","author":"Henry","year":"2020","journal-title":"Prat. Neurol. FMC"},{"key":"ref_44","first-page":"197","article-title":"Clinical quandaries posed by concurrent human immunodeficiency virus (HIV) and West Nile virus (WNV) infections: Case report","volume":"37","author":"Momah","year":"2020","journal-title":"West Afr. J. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"109207","DOI":"10.1016\/j.clim.2022.109207","article-title":"An HIV patient with West Nile encephalitis and amphiphysin antibodies\u2014More on \u201cWest Nile infection triggering autoimmune encephalitis: Pathophysiological and therapeutic implications\u201d by Moutsopoulos et al","volume":"246","author":"Arcilla","year":"2023","journal-title":"Clin. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Rakotomalala, F.A., Bouillin, J., Randriarimanana, S.D., Thaurignac, G., Maharavo, L., Raberahona, M., Razafindrakoto, L., Rasoanarivo, J., Rakoto-Andrianarivelo, M., and Rakoto, D.A.D. (2023). High seroprevalence of IgG antibodies to multiple arboviruses in people living with HIV (PLWHIV) in Madagascar. Viruses, 15.","DOI":"10.3390\/v15112258"},{"key":"ref_47","first-page":"e220369","article-title":"An uncommon cause of severe polyradiculopathy","volume":"2","author":"Gupta","year":"2023","journal-title":"Ann. Intern. Med. Clin. Cases"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1007\/s00415-023-11735-w","article-title":"Encephalitis in HIV-infected adults in the antiretroviral therapy era","volume":"270","author":"Ramirez","year":"2023","journal-title":"J. Neurol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"23247096241267132","DOI":"10.1177\/23247096241267132","article-title":"Catastrophic case of West Nile virus rhombencephalitis in AIDS","volume":"12","author":"Sharma","year":"2024","journal-title":"J. Investig. Med. High Impact Case Rep."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e2548229","DOI":"10.1001\/jamanetworkopen.2025.48229","article-title":"Risk factors for West Nile neuroinvasive disease and mortality in the US, 2013\u20132024","volume":"8","author":"Judson","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Tiecco, G., Castilletti, C., Pavesi, A., Accordini, S., Gianesini, N., Logiudice, J., Mantovani, R.P., Rossi, B., Chesini, L.M., and Calza, S. (2026). Prevalence and characterization of West Nile virus infections among people living with HIV in Northern Italy: A sero-repository analysis. Infection.","DOI":"10.1007\/s15010-026-02919-3"},{"key":"ref_52","unstructured":"Centers for Disease Control and Prevention (2026, August 22). Clinical Treatment and Prevention: West Nile Virus, Available online: https:\/\/www.cdc.gov\/west-nile-virus\/hcp\/treatment-prevention\/index.html."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.3201\/eid2511.190537","article-title":"Lack of efficacy of high-titered immunoglobulin in patients with West Nile virus central nervous system disease","volume":"25","author":"Gnann","year":"2019","journal-title":"Emerg. Infect. Dis."},{"key":"ref_54","first-page":"EVIDoa2500169","article-title":"West Nile virus-neutralizing plasma for West Nile virus disease","volume":"5","author":"Barda","year":"2026","journal-title":"NEJM Evid."},{"key":"ref_55","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents (2026, August 22). Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV: Initiation of Antiretroviral Therapy. Department of Health and Human Services, Available online: https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/hiv-clinical-guidelines-adult-and-adolescent-arv\/initiation-antiretroviral-therapy."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Kaiser, J.A., and Barrett, A.D.T. (2019). Twenty years of progress toward West Nile virus vaccine development. Viruses, 11.","DOI":"10.3390\/v11090823"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1056\/NEJMp2301816","article-title":"Combating West Nile virus disease\u2014Time to revisit vaccination","volume":"388","author":"Gould","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_58","unstructured":"European Centre for Disease Prevention and Control (2026, August 22). World Mosquito Day 2026: Europe Must Upgrade Control Tools as Disease Risks Rise. Available online: https:\/\/www.ecdc.europa.eu\/en\/news-events\/world-mosquito-day-2026-europe-must-upgrade-control-tools-disease-risks-rise."}],"container-title":["Tropical Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2414-6366\/11\/9\/250\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T09:55:17Z","timestamp":1788429317000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2414-6366\/11\/9\/250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":58,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["tropicalmed11090250"],"URL":"https:\/\/doi.org\/10.3390\/tropicalmed11090250","relation":{},"ISSN":["2414-6366"],"issn-type":[{"value":"2414-6366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]}}}